Bharat Serums and Vaccines Limited   Report issue

For profit Phase 2 Phase 3
Founded: Navi MumbaI India (1971)

Organization Overview

First Clinical Trial
2009
NCT00876824
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Bharat Serums and Vaccines Limited | Bharat Serums and Vaccines Ltd

Active Ingredients

Drugs in Phase 3 Trials (3)

amphotericin b (fungizone) (1 trial)

follitropin alfa (Gonal-F) (1 trial)

leuprolide (lupron) (1 trial)

Drugs in Phase 2 Trials (1)

equine covid-19 antiserum (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leishmaniasis (Phase 3)

Leishmaniasis, Visceral (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4